Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization, a ...

Please provide your email address to receive an email when new articles are posted on . Outcomes may vary among different fixed-dose combination inhalers for COPD. Fewer severe acute exacerbations ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive pulmonary disease (COPD).It contains an inhaled corticosteroid called ...

It was an ICS [inhaled corticosteroid] monotherapy, and then you moved to combination. We saw in the market that the majority of providers moved to combination therapy. It makes sense.

Key Considerations in COPD When Utilizing Combination Therapy. EP: 5.Implementing Inhaled Corticosteroids ... [NCT0346742]. It evaluated single vs multiple inhaler triple therapy for COPD.

The other single-inhaler on the market for COPD triple therapy, fluticasone-umeclidinium-vilanterol, is a dry-powder inhaler that does not contain hydrofluoroalkane-134a.

The combination of three medications in one inhaler helps control symptoms of COPD when taken regularly. But they aren't a substitute for a rescue inhaler and don't relieve sudden breathing ...

These medications can include bronchodilators, inhaled steroids, combination inhalers, oral steroids, phosphodiesterase-4 inhibitors, theophylline and antibiotics.

Across all treatment groups, more patients had moderate COPD (FEV 1 50% to 80% predicted normal) or severe COPD (FEV 1 30% to less than 50% predicted normal) at baseline than very severe COPD.

Use of inhaled ICSs was associated with a 19% increased fracture risk when compared to treatment without ICSs (RR 1.19, 95% CI 1.04-1.37), and that risk held steady when treatment lasted 12 months ...

Among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, newly prescribed long-acting beta-agonists and inhaled corticosteroid combination therapy ...

The U.S. Food and Drug Administration said yesterday that it has given approval for the first generic of the Symbicort inhaler to treat asthma and COPD. Symbicort is a combination of budesonide ...